Consequently, the high expression of E2F1 and E2F2, alongside RB1 inactivation and activation of downstream oncogenes, constitutes a complex regulatory network that significantly influences the onset, progression, and prognosis of lung cancer, particularly NSCLC. The gene discussed is E2F2; the disease is lung carcinoma.